Metsera (MTSR) Competitors $28.39 -1.06 (-3.60%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock MTSR vs. MRNA, RGC, VTRS, QGEN, ASND, BBIO, BPMC, VRNA, ROIV, and ELANShould you be buying Metsera stock or one of its competitors? The main competitors of Metsera include Moderna (MRNA), Regencell Bioscience (RGC), Viatris (VTRS), Qiagen (QGEN), Ascendis Pharma A/S (ASND), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. Metsera vs. Its Competitors Moderna Regencell Bioscience Viatris Qiagen Ascendis Pharma A/S BridgeBio Pharma Blueprint Medicines Verona Pharma PLC American Depositary Share Roivant Sciences Elanco Animal Health Moderna (NASDAQ:MRNA) and Metsera (NASDAQ:MTSR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Which has preferable valuation & earnings, MRNA or MTSR? Metsera has lower revenue, but higher earnings than Moderna. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioModerna$3.24B3.57-$3.56B-$8.73-3.42MetseraN/AN/A-$209.13MN/AN/A Is MRNA or MTSR more profitable? Metsera has a net margin of 0.00% compared to Moderna's net margin of -105.67%. Metsera's return on equity of 0.00% beat Moderna's return on equity.Company Net Margins Return on Equity Return on Assets Moderna-105.67% -28.69% -21.94% Metsera N/A N/A N/A Do analysts rate MRNA or MTSR? Moderna currently has a consensus target price of $46.61, suggesting a potential upside of 55.89%. Metsera has a consensus target price of $55.00, suggesting a potential upside of 93.73%. Given Metsera's stronger consensus rating and higher probable upside, analysts plainly believe Metsera is more favorable than Moderna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moderna 4 Sell rating(s) 15 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.04Metsera 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of MRNA or MTSR? 75.3% of Moderna shares are owned by institutional investors. 11.0% of Moderna shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor MRNA or MTSR? In the previous week, Moderna had 15 more articles in the media than Metsera. MarketBeat recorded 16 mentions for Moderna and 1 mentions for Metsera. Metsera's average media sentiment score of 0.59 beat Moderna's score of 0.42 indicating that Metsera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moderna 5 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Metsera 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMetsera beats Moderna on 8 of the 13 factors compared between the two stocks. Get Metsera News Delivered to You Automatically Sign up to receive the latest news and ratings for MTSR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MTSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MTSR vs. The Competition Export to ExcelMetricMetseraMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.09B$2.91B$5.52B$9.02BDividend YieldN/A2.44%5.24%4.05%P/E RatioN/A20.4427.2220.08Price / SalesN/A190.25381.5993.26Price / CashN/A41.7026.2128.59Price / Book-11.547.397.945.55Net Income-$209.13M-$55.04M$3.17B$248.49M7 Day Performance5.62%2.51%1.79%4.87%1 Month Performance3.27%-0.21%1.27%6.63%1 Year PerformanceN/A3.41%33.57%20.38% Metsera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MTSRMetseraN/A$28.39-3.6%$55.00+93.7%N/A$3.09BN/A0.0081MRNAModerna4.3662 of 5 stars$30.47+0.6%$46.61+53.0%-74.7%$11.79B$3.24B-3.495,800RGCRegencell Bioscience0.3761 of 5 stars$22.99+121.9%N/AN/A$11.37BN/A0.0010Gap UpHigh Trading VolumeVTRSViatris2.6666 of 5 stars$9.25-1.0%$10.40+12.4%-10.9%$10.94B$14.74B-2.9232,000QGENQiagen3.8552 of 5 stars$48.34-0.6%$49.40+2.2%+18.8%$10.75B$1.98B121.205,765Dividend AnnouncementASNDAscendis Pharma A/S3.5825 of 5 stars$174.07+0.6%$220.67+26.8%+29.6%$10.65B$393.54M-27.721,017Positive NewsBBIOBridgeBio Pharma4.6709 of 5 stars$43.71+2.0%$58.85+34.6%+68.9%$8.35B$221.90M-12.38400BPMCBlueprint Medicines1.3673 of 5 stars$128.27+0.1%$128.06-0.2%+15.0%$8.29B$508.82M-51.93640VRNAVerona Pharma PLC American Depositary Share2.6235 of 5 stars$91.18+1.2%$107.36+17.7%+466.1%$7.79B$42.28M-45.5930Positive NewsROIVRoivant Sciences1.5084 of 5 stars$10.85-1.1%$17.50+61.4%+0.8%$7.47B$29.05M-43.38860ELANElanco Animal Health2.3497 of 5 stars$14.64-0.5%$15.33+4.7%+1.8%$7.27B$4.44B19.789,000Analyst Upgrade Related Companies and Tools Related Companies MRNA Alternatives RGC Alternatives VTRS Alternatives QGEN Alternatives ASND Alternatives BBIO Alternatives BPMC Alternatives VRNA Alternatives ROIV Alternatives ELAN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MTSR) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metsera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metsera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MTSR Stock Alerts